Tandem Diabetes Care Inc
NASDAQ:TNDM
Tandem Diabetes Care Inc
Operating Expenses
Tandem Diabetes Care Inc
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tandem Diabetes Care Inc
NASDAQ:TNDM
|
Operating Expenses
-$526.5m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-23%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Operating Expenses
-$6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-7%
|
|
Boston Scientific Corp
NYSE:BSX
|
Operating Expenses
-$7.7B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-7%
|
|
Stryker Corp
NYSE:SYK
|
Operating Expenses
-$8.9B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-9%
|
|
Abbott Laboratories
NYSE:ABT
|
Operating Expenses
-$15.7B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-7%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Operating Expenses
-$3B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-14%
|
See Also
What is Tandem Diabetes Care Inc's Operating Expenses?
Operating Expenses
-526.5m
USD
Based on the financial report for Mar 31, 2024, Tandem Diabetes Care Inc's Operating Expenses amounts to -526.5m USD.
What is Tandem Diabetes Care Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-23%
Over the last year, the Operating Expenses growth was 14%. The average annual Operating Expenses growth rates for Tandem Diabetes Care Inc have been -23% over the past three years , -27% over the past five years , and -23% over the past ten years .